RecruitingGlenohumeral Osteoarthritis
Poly vs Hybrid Glenoid in Stemless aTSA
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Participants are randomized 1:1 to receive either a cemented all-polyethylene pegged glenoid or a hybrid trabecular titanium-pegged glenoid during anatomic total shoulder arthroplasty. Multicentre, stratified block randomization with variable block sizes; patient- and assessor-blinded.
Sponsor: Spaarne Gasthuis
You may qualify if…
- ✓ \-
- ✓ In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- ✓ 1. Both genders;
- ✓ 2. Age 18 years old;
- ✓ 3. Life expectancy over 5 years;
- ✓ 4. Patient has symptomatic shoulder osteoarthritis for more than 1 year and is submitted to previous conservative non-surgical treatments;
- ✓ 5. Patient is requiring primary unilateral or staged bilateral anatomic arthroplasty based on physical examination, medical history and X ray examination. (In cases where bilateral aTSA's are indicated, the patient will be included for the second aTSA again when the patient meets the inclusion criteria);
- ✓ 6. Good bone quality evaluated by the investigator on the basis of a risk factors analysis and the intraoperative estimation;
You may not qualify if…
- ✕ 1. Patient requiring revision shoulder arthroplasty;
- ✕ 2. Osteoporosis with a history of non-traumatic fractures;
- ✕ 3. Steroid injections within the previous 6 months;
- ✕ 4. Contralateral shoulder replacement within the previous 3 months;
- ✕ 5. Meta-epiphyseal bony defect (including large cysts);
- ✕ 6. Significant proven or suspicious infection of the target shoulder or any serious infectious disease
- ✕ 7. Significant neurological or musculoskeletal disorders that may compromise functional recovery;
- ✕ 8. Known or suspicious hypersensitivity to the metal or other materials of the implant;
Source: ClinicalTrials.gov · NCT07520721 · last updated 2026-04-09